Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 99, Issue 1, Pages 72-84
Publisher
Springer Nature
Online
2018-10-23
DOI
10.1038/s41374-018-0114-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug response prediction in high-risk multiple myeloma
- (2018) A.J. Vangsted et al. GENE
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
- (2018) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs
- (2017) Masanobu Tsubaki et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
- (2017) Meletios A Dimopoulos et al. LANCET ONCOLOGY
- Updated results of a phase 2 study of panobinostat combined with melphalan, thalidomide and prednisone (MPT) in relapsed/refractory multiple myeloma
- (2017) Massimo Offidani et al. LEUKEMIA & LYMPHOMA
- Proteasome inhibitors in cancer therapy
- (2017) Elisabet E. Manasanch et al. Nature Reviews Clinical Oncology
- Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
- (2016) Sonja Zweegman et al. BLOOD
- Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma
- (2016) Elena Viziteu et al. BRITISH JOURNAL OF CANCER
- Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways
- (2016) Jun Wan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- RANK-RANKL interactions are involved in cell adhesion-mediated drug resistance in multiple myeloma cell lines
- (2016) Masanobu Tsubaki et al. TUMOR BIOLOGY
- Microenvironment drug resistance in multiple myeloma: emerging new players
- (2016) Lucia Di Marzo et al. Oncotarget
- Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study
- (2015) María Victoria Mateos et al. AMERICAN JOURNAL OF HEMATOLOGY
- Frontline therapy of multiple myeloma
- (2015) P. Moreau et al. BLOOD
- A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
- (2015) A. Gulla et al. CLINICAL CANCER RESEARCH
- Novel therapeutic strategies for multiple myeloma
- (2015) Naoya Mimura et al. EXPERIMENTAL HEMATOLOGY
- The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1 inhibition in myeloma cells
- (2015) P. Storti et al. HAEMATOLOGICA
- PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis
- (2015) Cheng Zhang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Regulation of Bim in Health and Disease
- (2015) Ronit Vogt Sionov et al. Oncotarget
- The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1 inhibition in myeloma cells
- (2015) P. Storti et al. HAEMATOLOGICA
- Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma
- (2015) Enrica Borsi et al. Oncotarget
- Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia
- (2013) V. Gagne et al. CLINICAL CANCER RESEARCH
- Radiation-induced mitotic cell death and glioblastoma radioresistance: A new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1alpha and survivin in U87 cells
- (2013) Olivia Lanvin et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugs
- (2013) Masanobu Tsubaki et al. EUROPEAN JOURNAL OF CANCER
- The Oncogene HER2/neu (ERBB2) Requires the Hypoxia-inducible Factor HIF-1 for Mammary Tumor Growth and Anoikis Resistance
- (2013) Kelly A. Whelan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells
- (2013) Masanobu Tsubaki et al. LEUKEMIA RESEARCH
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
- (2013) Raul Aguirre-Gamboa et al. PLoS One
- Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
- (2012) H Ludwig et al. LEUKEMIA
- Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells
- (2012) Masanobu Tsubaki et al. LEUKEMIA RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Cyclophosphamide-induced apoptosis in A431 cells is inhibited by fucosyltransferase IV
- (2011) Xuesong Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
- (2010) J. A. Richter-Larrea et al. BLOOD
- Relationship of survivin to clinical drug resistance in Burkitt’s lymphoma of the head and neck region
- (2010) Manal M. Zyada MEDICAL ONCOLOGY
- The Novel, Proteasome-Independent NF- B Inhibitor V1810 Induces Apoptosis and Cell Cycle Arrest in Multiple Myeloma and Overcomes NF- B-Mediated Drug Resistance
- (2010) F. G. Meinel et al. MOLECULAR CANCER THERAPEUTICS
- The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma
- (2009) Mathilde Romagnoli et al. BRITISH JOURNAL OF HAEMATOLOGY
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer
- (2009) Yu-Qing Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started